NOS3 and glomerulosclerosis: Another study showed that PAR1 and PAR2 inhibitors improved kidney injury in Akita mice with reduced eNOS expression and that the combination of these inhibitors additively reduced albuminuria and glomerulosclerosis with a reduction in inflammation and fibrosis markers [112].